Organigram Global Inc. (OGI)
NEO-L 
Summary
OGI Chart
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.01 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.05 per share a year ago.
OrganiGram (OGI) Reports Q1 Loss, Lags Revenue Estimates
OrganiGram (OGI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.05 per share a year ago.
Organigram: Premium Pivot Signals Further Margin Expansion
Organigram reported solid Q4 earnings, highlighted by achieving a record gross margin and issuing a net revenue guidance implying sustained double-digit organic growth. Quebec's recent vape launch could boost Organigram's Canadian market share, while consumer shift to quality experiences could boost sales of higher-margin liquid diamond vapes. Organigram's expanded capacity and adoption of seed-based cultivation reduce its cost per gram while offering opportunities to increase exports to higher-margin international markets.
Organigram Global Inc. (OGI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Organigram Global Inc. ever had a stock split?
Organigram Global Inc. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | James H. Yamanaka CEO | NEO-L Exchange | CA68617J1003 ISIN |
| CA Country | 1,093 Employees | - Last Dividend | 7 Jul 2023 Last Split | - IPO Date |
Overview
Organigram Holdings Inc. specializes in the production and sale of cannabis and its derivatives within Canada, focusing on both medicinal and recreational sectors. Since its establishment in 2010, the company has expanded its operations to include a diverse range of cannabis products, catering to a variety of consumer preferences and medical needs. Based in Toronto, Canada, Organigram has successfully positioned itself in the competitive cannabis market through a strategic approach that involves wholesale and direct-to-consumer sales channels. This approach allows Organigram to distribute its products across the nation, ensuring wide availability to both medical retailers and adult-use consumers.
Products and Services
The product lineup of Organigram Holdings Inc. spans across both medical and recreational sectors, offering a broad spectrum of cannabis-derived products. The company's dedication to quality and variety is evident in its comprehensive range of offerings.
- Medical Cannabis Products: These include whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates. Aimed at medical retailers, these products are designed to meet the stringent requirements for medical-use cannabis, emphasizing purity, efficacy, and consistency.
- Adult Use Recreational Cannabis: Under its array of brands such as SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian, Organigram caters to the adult-use recreational market. The diverse product range includes:
- Whole Flower & Milled Flower: Traditional cannabis products for smoking and inhalation methods.
- Pre-Rolls & Infused Pre-Rolls: Convenient, ready-to-use cannabis cigarettes for those seeking ease of use.
- Vapes: A modern alternative to smoking, offering discrete consumption and varying flavors and potencies.
- Gummies & Concentrates: Edible and potent concentrate forms of cannabis, catering to varied consumer preferences.
- Wholesale and Consumer Sales: Besides direct sales, Organigram also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and derivative-based products to retailers and wholesalers for the adult-use recreational market. This aspect of the business allows for a broad distribution network across Canada, reaching a wide customer base.
